Evidence map›Paper›PMID 29932958›Full record

ReviewFrontiers in neuroendocrinology2018

Orexins and stress.

Laura A Grafe, Seema Bhatnagar

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06843187 (Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06843187 phase2terminatednot on this mapstarted 2024, after this paper: background citation

Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder: A Pilot Randomized Controlled Trial

TypeinterventionalSponsorUnity Health TorontoRan2024 to 2026Enrolled30ConditionsMajor Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric DisorderArmsLemborexant, Placebo
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Orexinergic responses to environmental stressors in the zebrafish gut.Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology · 2026
    Article
  7. Review
  8. Review
  9. Orexinergic modulation of chronic jet lag-induced deficits in mouse cognitive flexibility.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Orexins/Hypocretins: Gatekeepers of Social Interaction and Motivation.International journal of molecular sciences · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Laura A GrafeDepartment of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Seema BhatnagarDepartment of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. Electronic address: bhatnagars@email.chop.edu.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

Training Program in Neurodevelopmental DisabilitiesT32NS007413 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI AMELIA J EISCH, ERIC D MARSH · 1998 to 2026
$8.9M
Sex differences in orexinsR01MH109975 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BHATNAGAR, SEEMA · 2016 to 2020
$2.1M
Orexins contribute to sex differences in habituation to stress and cognitive functionF32MH109269 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI GRAFE, LAURA · 2015 to 2017
$67k
NIMH NIH HHS F32 MH109269NIMH NIH HHS R01 MH109975NINDS NIH HHS T32 NS007413
6 · The paper itself

Abstract

The neuropeptides orexins are important in regulating the neurobiological systems that respond to stressful stimuli. Furthermore, orexins are known to play a role many of the phenotypes associated with stress-related mental illness such as changes in cognition, sleep-wake states, and appetite. Interestingly, orexins are altered in stress-related psychiatric disorders such as Major Depressive Disorder and Anxiety Disorders. Thus, orexins may be a potential target for treatment of these disorders. In this review, we will focus on what is known about the role of orexins in acute and repeated stress, in stress-induced phenotypes relevant to psychiatric illness in preclinical models, and in stress-related psychiatric illness in humans. We will also briefly discuss how orexins may contribute to sex differences in the stress response and subsequent phenotypes relevant to mental health, as many stress-related psychiatric disorders are twice as prevalent in women.

Indexed as

AnimalsAnxiety DisordersFemaleHumansHypothalamo-Hypophyseal SystemMajor Depressive DisorderMaleOrexinsPituitary-Adrenal SystemStress, PsychologicalOrexinsAppetiteCognitionHabituationHPA axisHypocretinsOrexinsSleepStress

Identifiers

PMID29932958
PMCPMC6345253
OpenAlexW2809035612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.